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Unmanipulated native fat exposed 
to high-energy diet, but not autologous grafted 
fat by itself, may lead to overexpression of Ki67 
and PAI-1
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Abstract 
Background: Although its unclear oncological risk, which led to more than 20 years of prohibition of its use, fat graft‑
ing to the breast is widely used nowadays even for aesthetic purposes. Thus, we proposed an experimental model in 
rats to analyze the inflammatory activity, cellular proliferation and levels of Plasminogen Activator Inhibitor (PAI‑1) in 
grafted fat, and in native fat exposed to high‑energy diet in order to study the oncological potential of fat tissue.
Methods: Samples of grafted fat of rats on regular‑energy diet were compared with paired samples of native fat 
from the same rat on regular‑energy diet and on high‑energy diet in a different time. Analysis involved microscopic 
comparisons using hematoxylin‑eosin staining, immunohistochemistry with anti‑CD68‑labelled macrophages, and 
gene expression of Ki‑67 and PAI‑1.
Results: Hematoxylin‑eosin staining analyses did not find any atypical cellular infiltration or unusual tissue types in 
the samples of grafted fat. The inflammatory status, assessed through immunohistochemical identification of CD68‑
labelled macrophages, was similar among samples of native fat and grafted fat of rat on regular‑energy diet and of 
native fat of rats on high‑energy diet. Real‑time PCR revealed that high‑energy diet, but not fat grafting, leads to prolif‑
erative status on adipose tissue (overexpression of ki‑67, p = 0.046) and raised its PAI‑1 levels, p < 0.001.
Conclusion: While the native adipose tissue overexpressed PAI‑1 and KI67 when exposed to high‑energy diet, the 
grafted fat by itself was unable to induce cellular proliferation, chronic inflammatory activity and/or elevation of PAI‑1 
levels.
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Background
In 1895, Czerny described the first breast reconstruc-
tion, which was performed with adipose tissue, using a 
large lipoma from the dorsal flank to fill defects resulted 
from the excision of a breast benign lesion (Claro et  al. 
2012). Since then, the adipose tissue (as fat grafting or 
pedicle flaps from great omentum or subcutaneous tis-
sue) became often used for breast reconstruction (Claro 
et al. 2012, 2015; Abbott and White 1986; Calderoli and 
Keiling 1985; Góes 2010; Illouz 1988; Kiricuta 1963). Its 
popularity though, appeared after the advent of liposuc-
tion in the 1970s, when the aspirated fat harvested from 
many body areas could be reinjected to the breast (Claro 
et  al. 2012). So, the autologous fat grafting began to be 
used for aesthetic purposes as well, once it is performed 
using a non-immunogenic substitute/filler, through a ver-
satile and inexpensive procedure obtained usually with-
out donor site morbidity (Claro et al. 2012).
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However, it was suggested that adipose tissue might 
represent an oncological risk for breast cancer, what led 
the American Society of Plastic Surgeons to prohibit 
its use to the female breast in 1987 (Claro et  al. 2012; 
ASPRS 1987; Chalmers and Newing 1986). Most of this 
theory was raised after some studies have correlated 
the higher potential of breast cancer in obese people 
(Carter and Church 2009, 2012). Long since great focus 
to adipose tissue in obesity has been given, such as its 
comparisons between the omentum and subcutane-
ous tissue in many disorders like diabetes and cancer 
(Harman-Boehm et  al. 2007; Rodbell 1964; Tam et  al. 
2012; Weisberg et  al. 2003). The most notable hypoth-
esis related to adipocytes and breast cancer is based on 
the inflammatory potential of these cells, which release 
adipokines that may lead to chronic inflammation and 
cell proliferation (once the risk for metabolic disorders 
and breast cancer seems to be higher in obese people) 
(Claro et  al. 2012, 2015; Chalmers and Newing 1986; 
Carter and Church 2009, 2012). However, this hypoth-
esis has not been sustained for the procedure of lipofill-
ing to the breast in clinical practice.
Thereupon, the lack of evidence for lipofilling and 
breast cancer almost 20  years after its prohibition lead 
to the publication of some case series reporting breast 
reconstruction with fat grafting in early 2000’s, with 
good results and without report of higher cancer recur-
rence than other well established reconstruction proce-
dures (Claro et  al. 2012; Góes and Macedo 2006). This 
demanded in 2009, a review of the prohibition imposed 
by the American Society of Plastic Surgeons that, owing 
to lack of evidence, failed to prohibit the use of autolo-
gous adipose tissue to the breast, although they do not 
recommend it (Gutowski and Force 2009).
Since then, many cases series and reviews remain fail-
ing to demonstrate higher recurrence rate of breast can-
cer among women treated with fat grafting (Claro et al. 
2012, 2015). So, great effort in experimental field has 
been made in order to analyze the oncological poten-
tial of fat cells to the breast. Some laboratorial studies 
have focused on adipocytes in vitro, while others have 
analyzed fat cells from people due to the great difficulty 
in established an effective experimental model in vivo 
(Carter and Church 2009, 2012; Baglioni et  al. 2009; 
Baumert et al. 2007; Lin et al. 2001; Wyckoff et al. 2004). 
Most of these studies even compared fat cells from dif-
ferent fat compartments and/or from people in different 
conditions, such as obesity and non-obesity. Regard-
ing these issues, great focus to Plasminogen Activator 
Inhibitor-1 (PAI-1) complex has been taken, because it 
is a protein found in high concentration in adipose tis-
sue of obese people and/or of breasts with cancer and 
so, can be used as a marker for them (Carter and Church 
2009, 2012; Harman-Boehm et  al. 2007; Baglioni et  al. 
2009; Andreasen et  al. 2000; Bianchi et  al. 1995; Binder 
et  al. 2002; Cojocaru et  al. 2012; Condeelis and Pollard 
2006; Dhanasekaran et al. 2012; Di Gregorio et al. 2005; 
Gomes-Giacoia et  al. 2013; Goswami et  al. 2005; Gut-
ierrez et al. 2000; Lin et al. 2002; Sumiyoshi et al. 1991). 
Some of these studies were able to demonstrate the onco-
logical potential of the adipocytes, primary in obese sub-
jects. However, this potential remains uncertain for the 
procedure of lipofilling to the breast by itself, and was 
not observed in clinical practice. One believed reason for 
this, raised by us, is that the breast bed, even after a com-
plete resection of mammary tissue, remains with a large 
amount of native adipose tissue. So, for locally oncologi-
cal potential, the adipokines released from transposed/
grafted fat cells would be the same of those released 
from native adipocytes that are already surrounding any 
remaining mammary glandular cell. And systemically, 
considering that the donor fat cells are from the same 
patient that will receive them, the serum concentration 
of any pro-oncological factor resulting from these adipo-
cytes will remain the same after the procedure.
Moreover, beyond the adipocyte, some theories raised 
doubts regarding the procedure by itself, due to the great 
angiogenic potential of the adipose tissue observed in 
some clinical and experimental studies (Dhanasekaran 
et al. 2012; Figueiredo et al. 2010; Goldsmith et al. 1967; 
Liebermann-Meffert 2000; Morison 1903; O’Shaughnessy 
1937; Oloumi et al. 2006; Williams and White 1991), that 
may lead to chronic inflammation and cell proliferation 
to the microenvironment of lipofilling host site and its 
surroundings. Thus, there are some issues that must be 
considered when studying fat grafting: (1) the unpredict-
able amount of grafted fat present in the sample extracted 
from the host site, because the long-term graft retention 
is inaccurate and its absorption can vary from less than 
10% to more than 90%; (2) as fat graft is composed not 
only by adipocytes but also by many other cells and com-
ponents present in fat tissue, the whole elements of the 
adipose tissue though, must be analyzed after fat grafting; 
(3) the grafted tissue must be analyzed in vivo in order 
to study its behavior in the host site and of its surround-
ings and; (4) the subjects must be genetically similar and, 
as controlled as possible, in relation to its diet intake and 
lifestyle.
Thus, an experimental model was proposed taken into 
account all the challenges reported above in order to ana-
lyze the carcinogenic potential of autologous fat grafting 
procedure focusing on its main suggested threats to the 
host site (higher concentration of PAI-1, chronic inflam-
mation activity and higher proliferation rate). We also 
aimed to compare the findings for this potential resulted 
from the procedure by itself to those represented by the 
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unmanipulated native fat tissue when exposed to high-
energy diet.
Methods
Study design and sample size
A comparative, paired and controlled experimental study 
was conducted using eight female Sprague–Dawley rats 
(Rattus norvegicus) from the same dam; obtained at 
56-day-old from the Central Reproduction Centre at the 
State University of Campinas (UNICAMP), Campinas-
SP, Brazil. The Sprague–Dawley rat was chosen because it 
is a breed prone to develop breast cancer when exposed 
to some risk factors (Russo and Russo 1996; Russo et al. 
1983; Shan et al. 2004). Considering that a variable (PAI-1 
levels) was used as positive and a negative control for the 
same tissue of the same rat in different times, a sample 
size of three rats was defined as enough. However, con-
sidering possible exclusions during the evolution of the 
study, the sample size was set to eight rats.
The study followed the ARRIVE guidelines (Kilkenny 
et  al. 2010) and was approved by the UNICAMP Com-
mittee for Ethics in Animal Research (protocol no. 2210-
1). The rats remained in the animal-breeding center at 
the Institute of Biology, UNICAMP from the beginning 
of the fattening period to the collection of the material 
for analysis. The rats were housed in isolated boxes that 
were cleaned daily under a 12-h/day light cycle at a con-
stant temperature of 22 ± 2°C. An overview of the study 
is summarized in Figure 1.
Experimental model proposed and adipose tissue chosen
In order to avoid bias related to the unpredictable 
amount of grafted fat present in the sample extracted 
from the host site, an experimental model was proposed 
using a pedicle fat graft of great omentum, instead of free 
fat graft from subcutaneous tissue, based on deep study 
of the literature, and discussions among researchers from 
some departments of biological institute and medical 
school at UNICAMP. Although they are from different 
embryological origin, the adipose tissue from omentum 
and subcutaneous tissue have the same cellular compo-
sition, with similar regenerative and physiological func-
tion, and even the same amount of stem cells able to 
differentiate into any mesenchymal tissue (Cancello et al. 
2006; Dicker et  al. 2009; Toyoda et  al. 2009). A differ-
ence identified between these two adipose tissues is the 
greater metabolic and inflammatory potential of the great 
omentum if compared to the subcutaneous tissue. These 
issues are stated as oncogenic risk for breast cancer, 
what became this model of fat grafting using fat tissue of 
omentum, instead of subcutaneous, even more sensitive. 
Thus, in order to avoid bias related to this and false-pos-
itive results, a control of native subcutaneous fat of the 
same rat was used as control for fat tissue similarity.
Dietary regimen and composition of diet
Cafeteria diet was used for 56  days, until the time of 
great omentum grafting (rats of 112-day-old), so we were 
able to analyze the carcinogenic potential of high-energy 
foods consumed by humans in adipose tissue. After the 
great omentum translocation, the cafeteria diet was 
replaced for standard rodent chow and water ad libitum 
for more 56 days (until rats’ age of 168-day-old).
The cafeteria diet consists of replacement of water 
for soft drinks ad libitum (Coca-cola®) and of standard 
rodent chow for a pellet made of 37.5% standard rodent 
chow, 25% peanuts, 25% chocolate, and 12.5% cookies, 
offered together with wafer, snacks, cakes, and biscuits 
(4.41 kcal/g, 43.1% from carbohydrates; 12.1% from pro-
teins, and 46.9% from fats). The standard rodent chow 
diet Nuvilab CR-1 (Nuvital, Brazil) has 2.63 kcal/g (Van-
zela et al. 2010). The cafeteria diet was used at the begin-
ning of the study when the rats were younger and so, less 
prone to bias due to other metabolic disorders related to 
age. With the cafeteria diet we were able to confirm that 
the changes in results were only due to the replacement 
of the diet on the same rat (from high-energy to regular-
energy) and so, analyze the influence of diet over the fat 
tissue and its oncological potential.
Surgical procedure
The rats underwent general anesthesia (intraperitoneally) 
at 112-day-old. The omentum grafting process was 
Figure 1 Flowchart overview of the study. OM unmanipulated native 
fat tissue of omentum of rats on cafeteria diet regimen (high‑energy 
diet), CO native fat tissue of omentum of rats in regular‑energy diet, 
used as post‑operative control, TO grafted fat tissue of omentum 
of rats in regular‑energy diet, SC fragment of unmanipulated native 
subcutaneous adipose tissue from the left iliac fossa used as control 
for fat tissue similarity, HE hematoxylin‑eosin.
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performed through a midline skin incision of approxi-
mately 4 cm. Subcutaneous dissection of the entire right 
hemi-abdomen followed by laparotomy with a 4-cm 
incision at abdominal midline. The great omentum was 
divided into three parts (three samples for the study): (1) 
one was made with 20 mm2 of the left pedicle flap in the 
left gastroepiploic branch and remained in the abdomi-
nal cavity (fat tissue control—CO); (2) a portion of the 
right flap (also 20 mm2) based on the right gastroepiploic 
branch was grafted into the subcutaneous layer in the 
upper right abdomen and fixed to the abdominal wall at 
its ends with 5.0 nylon (transposed omentum—TO); (3) 
the remaining central portion of omentum was used to 
analyze the influence of high-energy diet over fat tissue 
(omentum on high-energy diet—OM). The abdominal 
wall was closed with running sutures of 5.0 nylon except 
the upper 0.3 cm, which was left open for the passage of 
the translocated omental pedicle. Finally, the skin was 
closed with running sutures of 5.0 nylon.
The rats were euthanized at 8  weeks post-operatively 
(168-day-old). Three tissue samples were identified and 
extracted: native fat tissue of omentum (CO), the grated 
fat tissue (TO); and a fragment of unmanipulated native 
subcutaneous adipose tissue (SC) from the left iliac fossa 
(an area with abundant adipose tissue distant from the 
manipulated surgical site, thus free from any postopera-
tive inflammatory process).
Histological preparation and analysis
Each sample was immediately identified and introduced 
into a vial containing 10% buffered formalin. The tis-
sue samples were processed in the pathology laboratory. 
Sections of 4  μm of each sample were placed on glass 
slides, dehydrated and stained with hematoxylin-eosin 
(HE). The evaluation was performed by a single patholo-
gist blinded to the origin of the tissues (with the samples 
identified only by numbers and letters) with light micros-
copy, in order to identify the presence of cell populations 
that differ from the normal cells in the adipose tissue.
Immunohistochemistry
Immunohistochemistry using monoclonal anti-mouse 
anti-CD68 antibodies (clone Kp-1, Advance, Dako, 
Glostrup, Denmark) was used to identify the macrophage 
concentrations in each tissue type (Weisberg, Harman-
Boehm) according to the manufacturer’s instructions. A 
single pathologist, blinded to the origin of each sample, 
performed the immunohistochemical analysis. The num-
ber of anti-CD68 stained macrophages was counted in 
ten different randomly chosen areas in each processed 
slide at 40× magnification for each tissue sample. A cell 
was considered positive when the morphological aspects 
of a macrophage were observed with a marked cytoplasm 
outside the vascular lumen (Cancello et  al. 2006; Aron-
Wisnewsky et al. 2009).
Real‑time PCR
Total mRNA extraction was performed using TRI-
zol® Reagent protocol (Life Technologies, #15596018). 
Ki67 and PAI-1 mRNA expression were measured in all 
groups by Real Time PCR (ABI Prism 7500—Applied 
Biosystems). The primer Ki67 (Rn.PT.58.8428180.g) was 
obtained from Integrated DNA Technology (IDT), and 
PAI-1 (Rn01481341_m1) were purchased from Applied 
Biosystems. GAPDH (#4352339E—Applied Biosystems) 
was used as endogenous control. Each PCR contained 
40  ng of reverse-transcribed RNA, 0.25 μl of each spe-
cific primer, Taqman Universal master mix (#4369016—
Applied Biosystems), and RNase free water to a 10  μl 
final volume. Real-time data were analyzed using the 
Sequence Detector System 7500 (Applied Biosystems).
Statistical analyses
The normal distribution of the data was assessed using 
the Kolmogorov–Smirnov and Shapiro–Wilk tests. As 
the data were normally distributed, there were used 
paired t-test and analysis of variance (ANOVA, one way, 
and repeated measures) and Tukey test (post hoc) paired 
t-test for statistical comparisons. The values are given 
as mean ±  standard deviation (SD) and the significance 
level was 5%. The software used for the analysis was SPSS 
version 20 for MAC (IBM; Armonk, NY—EUA).
Results
One of the rats died on the 33rd day of high-energy diet, 
at 89-day-old, before the procedure of adipose tissue 
grafting. Then, seven rats remained and were used for 
analyses in this study. A complete healing of the surgical 
wound with full hair growth at the site was observed at 
time of samples extraction (rats’ age of 168-day-old). All 
samples revealed viable flaps under microscopic analy-
sis (without necrosis). No atypical cellular infiltration 
or unusual tissue types were observed in the samples of 
grafted fat.
High‑energy diet or fat grafting did not influence the 
inflammatory activity involving CD68 macrophages in fat 
tissue
Immunohistochemical analyses of the average concen-
tration of CD68-labelled macrophages (Figure  2) in 
unmanipulated native fat tissue samples of rats fed with 
high-energy food (OM) was 10.00 ± 4.02 macrophages/
field in 10 fields per animal; the average among samples 
of those fed with standard rodent chow was 10.17 ± 4.17 
in control native fat (CO); 6.60 ± 1.75 in grafted fat (TO), 
and 19.33 ± 5.60 in the subcutaneous fat used as control 
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for fat tissue similarity (SC). What represents that the 
inflammatory activity involving CD68 macrophages 
among all the adipose tissue samples were similar 
p = 0.246 (CI 95% 7.03–16.17), Figure 3.
The high‑energy diet represents higher proliferation rate 
in the adipose tissue environment
The gene expression level of Ki67 (Figure 4a) in the CO 
samples was 0.52 ± 0.03. A similar pattern was observed 
in the SC (0.51 ± 0.11) however; the level of 1.20 ± 0.00 
was significantly higher in the OM (ANOVA OM vs. CO 
and SC: p = 0.046, CI 95% 0.41–1.03).
The high‑energy diet, but not fat grafting procedure, leads 
to elevation of PAI‑1 levels in adipose tissue
Gene expression of PAI-1 (Figure  4b) revealed that 
its level in the OM of 12.63  ±  3.07 is significantly 
higher than those identified in CO (1.13  ±  0.32), SC 
(0.29 ±  0.12) and TO (3.44 ±  1.58), p  <  0.001, CI 95% 
0.01–6.88. The ANOVA test shows similar low levels of 
PAI-1 gene expression (p = 0.70) among samples of rats 
fed with standard rodent chow (CO, TO and SC).
Discussion
Our results showed that the grafted adipose tissue and 
its surroundings did not expressed inflammatory activity 
mediated by macrophages, higher cellular proliferation 
rate nor higher levels of PAI-1. However, high-energy diet 
leads to higher cellular proliferative rate in the unmanip-
ulated native adipose tissue (analyzed through Ki67) and 
higher levels of PAI-1.
Figure 2 CD68‑labelled macrophages (yellow arrow) in a fat tissue of rats fed with high‑energy food (OM) and in b grafted fat of rats in regular‑
energy diet (TO) (magnification ×400).
Figure 3 Immunohistochemical analyses of the concentration of 
CD68‑labelled macrophages (macrophages/10 fields) per animal 
in unmanipulated native fat tissue of omentum of rats fed with 
high‑energy food (OM), in native fat tissue of omentum of rats in 
regular‑energy diet (CO), in fat of omentum of rats in regular‑energy 
diet grafted to subcutaneous environment (TO) and in the fat tissue 
of unmanipulated native subcutaneous adipose tissue from the left 
iliac fossa (SC).
Figure 4 Gene expression level of a Ki67 and b PAI‑1. OM unmanipu‑
lated native fat tissue of omentum of rats on cafeteria diet regimen 
(high‑energy diet), CO native fat tissue of omentum of rats in regular‑
energy diet, used as post‑operative control, TO grafted fat tissue of 
omentum of rats in regular‑energy diet, SC fragment of unmanipu‑
lated native subcutaneous adipose tissue from the left iliac fossa used 
as control for fat tissue similarity.
Page 6 of 8Claro Jr. et al. SpringerPlus  (2015) 4:279 
It is known that the adipose tissue provides a source of 
stem cells (i.e., cells that are capable of differentiating into 
other cell types of the same embryonic origin) (Baglioni 
et al. 2009; Baumert et al. 2007; Dhanasekaran et al. 2012; 
Oloumi et  al. 2006; Kobayashi et  al. 2006) and exhibits 
great angiogenic potential (Figueiredo et al. 2010; Oloumi 
et  al. 2006) for restoring ischemic tissues and actinic 
lesions (Claro et  al. 2012; Illouz 1988; Goldsmith et  al. 
1967; Liebermann-Meffert 2000; Morison 1903; Williams 
and White 1991). The movement of this tissue from its 
primary site to a different environment might expose it 
to metaplasia. In the present study this theory was not 
proved, once the histological results using HE did not 
reveal the presence of cell metaplasia in the TO.
The CD68 is a membrane glycoprotein type 1, strongly 
expressed by tissue macrophages, present in inflam-
matory events of vascular and adipose tissues, usu-
ally related to fat metabolism. These macrophages have 
been cited as present in high concentration in adipose 
tissue of patients with plurimetabolic syndrome and/or 
insulin-resistance (Di Gregorio et  al. 2005), in athero-
sclerotic plaques (Cojocaru et  al. 2012), and in breasts 
with cancer (with unfavorable impact on disease inva-
sion and progression) (Lin et  al. 2001; Wyckoff et  al. 
2004; Condeelis and Pollard 2006; Goswami et al. 2005; 
Lin et al. 2002; Piras et al. 2005; Soeda et al. 2008; Offer-
sen et al. 2003). However, according to our findings, no 
connection was identified in literature between the level 
of CD68-labelled macrophages and obesity in patients 
without any metabolic disorder (Tam et  al. 2012; Di 
Gregorio et  al. 2005). What represents that those mac-
rophages levels in a tissue depend of inflammatory 
events and pathological chemotaxis from sick adipocyte 
mediators but not from healthy adipose tissue. In this 
study, the CD68 antigen was used to identify the chemo-
taxis potential of adipose tissue to attract CD68-labelled 
macrophages, which may represent a risk for breast 
cancer and/or its unfavorable evolution (Lin et al. 2001; 
Wyckoff et  al. 2004; Condeelis and Pollard 2006; Gos-
wami et al. 2005; Lin et al. 2002; Piras et al. 2005; Soeda 
et al. 2008).
Di Gregorio et  al. (2005) have shown that the CD68 
expression is also higher at the stromal vascular fraction 
of the adipose tissue than its adipocyte fraction. Consid-
ering that the angiogenesis is intense just after adipose 
tissue grafting or translocation (Figueiredo et  al. 2010), 
what represents one among many theories for its poten-
tial for breast cancer, a chronic higher concentration of 
CD68-labelled macrophage was expected. However, this 
data was not found in this study and the CD68 expres-
sion was similar in all adipose tissue samples. Therefore, 
adipose tissue grafting does not seem to generate chronic 
inflammatory activity involving CD68 macrophages 
that may lead to a carcinogenic potential in its host 
microenvironment.
Ki67 is a nuclear protein present in proliferating cells, 
but absent in resting cells. What means that ki67 is asso-
ciated with cell proliferation (Gerdes et  al. 1984; Path-
manathan and Balleine 2013; Rahmanzadeh et al. 2007). 
Nowadays, Ki67 scoring is used as a prognostic factor for 
early breast cancer and even as a predictor of its treat-
ment efficacy (Pathmanathan and Balleine 2013; Urruti-
coechea et al. 2005; Bullwinkel et al. 2006; Luporsi et al. 
2012; Inwald et al. 2013; Nishimura et al. 2010). The gene 
expression of Ki67 was used in order to evaluate the pro-
liferation rate of adipose tissue from different body com-
partments, as well as its behavior on high-energy diet and 
after its translocation to a different environment. The 
possibility of transposed fat creating a proliferative sta-
tus in the host microenvironment is considered mostly 
due to the knowledge that the adipose tissue promotes 
angiogenesis, deeply explored in the great omentum 
experiments (Baumert et al. 2007; Figueiredo et al. 2010; 
Goldsmith et  al. 1967; O’Shaughnessy 1937; Oloumi 
et  al. 2006), what theoretically may represent another 
threat for breast cancer. In this study, the adipose tissue 
per se, did not show any change in its proliferative rate 
according to its origin site or after its translocation to a 
different environment. However, a proliferative status 
was observed on samples of unmanipulated native fat 
exposed to a high-energy dietary regimen.
Plasminogen Activator Inhibitor 1 is a single-chain 
glycoprotein that acts as the primary regulator of plas-
minogen activation in vivo. It is secreted by several cells 
and participates in tissue repair processes (Binder et  al. 
2002; Gomes-Giacoia et  al. 2013; Sumiyoshi et  al. 1991; 
Jankun et al. 1993). High PAI-1 level correlates with obe-
sity, hyperinsulinemia, hyperglycemia, and hypertriglyc-
eridemia (Carter and Church 2009; Binder et  al. 2002). 
Some oncological conditions show high level of PAI-1 
as well. Its role in breast cancer has been widely studied, 
where it is involved in the decrease of apoptotic activity, 
degradation of extracellular matrix during tumor growth, 
invasion, and metastasis. High levels of PAI-1 in breast 
cancer thus, is linked to the poor prognosis of disease 
progression (Carter and Church 2009, 2012; Andreasen 
et  al. 2000; Bianchi et  al. 1995; Gomes-Giacoia et  al. 
2013; Gutierrez et al. 2000; Sumiyoshi et al. 1991; Offer-
sen et  al. 2003; Jankun et  al. 1993; Foekens et  al. 2000). 
Our study found high levels of PAI-1 only on unmanipu-
lated adipose tissue samples of rats fed with high-energy 
food, which posteriorly became low in the same rats 
after change of their diet regimen. Carter and Church 
(2012) demonstrated that the native mature fat cells of 
breast seems to represent a greater threat to breast can-
cer than fat cells from other regions and, even higher 
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than immature adipocytes or stem cells. In addition, fat 
cells are widely present in our body and there is no evi-
dence that a fat grafting procedure by itself would bring 
additional oncological risk to a region that is already sur-
rounded by adipose tissue.
Conclusion
We found in this study in rats that, while the unmanipu-
lated native adipose tissue overexpressed PAI-1 and KI67 
when exposed to high-energy diet, the grafted fat by 
itself was unable to induce cellular proliferation, chronic 
inflammatory activity and/or elevation of PAI-1 levels. 
This findings highlight that fat grafting procedure alone 
does not seem to change the oncological potential of its 
host microenvironment, however more experimental 
studies focusing on the fat grafting behavior in vivo must 
be made in order to confirm this issue.
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